ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients
March 01, 2021Treating critically ill COVID-19 patients with drugs typically used for rheumatoid arthritis may significantly improve survival, a landmark study has found. -
Roche’s arthritis drug shows effectiveness for ill patients in Covid-19 trial
November 23, 2020The UK’s Imperial College London has reported that early data from the REMAP-CAP trial showed Roche’s arthritis drug, Actemra (tocilizumab), is expected to reduce deaths and time spent in intensive care in critically ill patients with severe Covid-19. -
Fast tracks testing of COVID-19 therapies
April 14, 2020A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched at UPMC to address one of the most important debates during the COVID-19 pandemic.
Pharma Sources Insight January 2025
